Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018

162
-1

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
162
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018

  1. 1. Norway Cardiovascular Devices Investment Opportunities,Analysis and Forecasts to 2018Report Details:Published:September 2012No. of Pages: 350Price: Single User License – US$2500Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018SummaryGlobal Markets Direct’s new report, “Norway Cardiovascular Devices Investment Opportunities,Analysis and Forecasts to 2018” provides key market data on the Norway Cardiovascular Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within ten market categories – Cardiac Rhythm Management,Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves,Electrophysiology, Cardiovascular Surgery, External Defibrillators, Cardiac Assist Devices,Cardiovascular Monitoring and Diagnostic Devices and Cardiovascular Prosthetic Devices. Thereport also provides company shares and distribution shares data for each of the aforementionedmarket categories. The report is supplemented with global corporate-level profiles of the keymarket participants with information on company financials and pipeline products, whereveravailable.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by Global Markets Direct’s team of industry experts.Scope- Market size and company share data for Cardiovascular Devices market categories – CardiacRhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic HeartValves, Electrophysiology, Cardiovascular Surgery, External Defibrillators, Cardiac Assist Devices,Cardiovascular Monitoring and Diagnostic Devices and Cardiovascular Prosthetic Devices.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within ten market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the ten market categories.
  2. 2. - Global corporate-level profiles of key companies operating within the Norway CardiovascularDevices market.- Key players covered include Medtronic, Inc., Boston Scientific Corporation , St. Jude Medical,Inc., Abbott Laboratories , Cordis Corporation , Edwards Lifesciences Corporation and others.Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Norway CardiovascularDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/195359-norway-cardiovascular-devices-investment-opportunities-analysis-and-forecasts-to-2018.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 91.2 List of Figures 142 Introduction 192.1 What is This Report About? 193 Cardiovascular Devices In Norway 203.1 Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 203.2 Cardiovascular Devices, Norway, Company Share (2010-2011) 264 Cardiac Assist Devices In Norway 284.1 Cardiac Assist Devices Overall Revenue, (2004-2018) 284.1.1 Intra-Aortic Balloon Pumps, Revenue (2004-2018) 324.1.2 Ventricular Assist Devices, Revenue (2004-2018) 364.2 Cardiac Assist Devices Overall Volume (2004-2018) 404.2.1 Intra-Aortic Balloon Pumps, Volume (2004-2018) 424.2.2 Ventricular Assist Devices, Volume (2004-2018) 464.3 Cardiac Assist Devices Average Price (2004-2018) 504.4 Cardiac Assist Devices Distribution Share (2010-2011) 514.5 Cardiac Assist Devices, Norway, Company Share (2010-2011) 525 Cardiac Rhythm Management In Norway 545.1 Cardiac Rhythm Management Overall Revenue, (2004-2018) 54
  3. 3. 5.1.1 Cardiac Resynchronisation Therapy, Revenue (2004-2018) 585.1.2 Implantable Cardioverter Defibrillators, Revenue (2004-2018) 625.1.3 Pacemakers, Revenue (2004-2018) 665.2 Cardiac Rhythm Management Overall Volume (2004-2018) 705.2.1 Cardiac Resynchronisation Therapy, Volume (2004-2018) 745.2.2 Implantable Cardioverter Defibrillators, Volume (2004-2018) 785.2.3 Pacemakers, Volume (2004-2018) 825.3 Cardiac Rhythm Management Average Price (2004-2018) 855.4 Cardiac Rhythm Management Distribution Share (2010-2011) 875.5 Cardiac Rhythm Management, Norway, Company Share (2010-2011) 886 Cardiovascular Monitoring and Diagnostic Devices In Norway 906.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue, (2004-2018) 906.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2004-2018) 946.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2004-2018) 986.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2010-2011) 996.5 Cardiovascular Monitoring and Diagnostic Devices, Norway, Company Share (2010-2011) 1007 Cardiovascular Prosthetic Devices In Norway 1027.1 Cardiovascular Prosthetic Devices Overall Revenue, (2004-2018) 1027.1.1 Septal Occluders, Revenue (2004-2018) 1067.2 Cardiovascular Prosthetic Devices Overall Volume (2004-2018) 1107.2.1 Septal Occluders, Volume (2004-2018) 1147.3 Cardiovascular Prosthetic Devices Average Price (2004-2018) 1187.4 Cardiovascular Prosthetic Devices Distribution Share (2010-2011) 1197.5 Cardiovascular Prosthetic Devices, Norway, Company Share (2010-2011) 1208 Cardiovascular Surgery In Norway 1228.1 Cardiovascular Surgery Overall Revenue, (2004-2018) 1228.1.1 Beating Heart Surgery Systems, Revenue (2004-2018) 1268.1.2 Perfusion Disposables, Revenue (2004-2018) 1308.2 Cardiovascular Surgery Overall Volume (2004-2018) 1348.2.1 Beating Heart Surgery Systems, Volume (2004-2018) 1388.2.2 Perfusion Disposables, Volume (2004-2018) 1428.3 Cardiovascular Surgery Average Price (2004-2018) 1458.4 Cardiovascular Surgery Distribution Share (2010-2011) 1468.5 Cardiovascular Surgery, Norway, Company Share (2010-2011) 1479 Electrophysiology In Norway 1499.1 Electrophysiology Overall Revenue, (2004-2018) 1499.1.1 Electrophysiology Diagnostic Catheters, Revenue (2004-2018) 1539.1.2 Electrophysiology Ablation Catheters, Revenue (2004-2018) 1579.2 Electrophysiology Overall Volume (2004-2018) 1619.2.1 Electrophysiology Diagnostic Catheters, Volume (2004-2018) 1649.2.2 Electrophysiology Ablation Catheters, Volume (2004-2018) 1689.3 Electrophysiology Average Price (2004-2018) 172
  4. 4. 9.4 Electrophysiology Distribution Share (2010-2011) 1739.5 Electrophysiology, Norway, Company Share (2010-2011) 17410 External Defibrillators In Norway 17610.1 External Defibrillators Overall Revenue, (2004-2018) 17610.2 External Defibrillators Overall Volume (2004-2018) 18010.3 External Defibrillators Average Price (2004-2018) 18410.4 External Defibrillators Distribution Share (2010-2011) 18510.5 External Defibrillators, Norway, Company Share (2010-2011) 18611 Interventional Cardiology In Norway 18811.1 Interventional Cardiology Overall Revenue, (2004-2018) 18811.1.1 Cardiac Catheters, Revenue (2004-2018) 19211.1.2 Coronary Stents, Revenue (2004-2018) 19611.1.3 PTCA Balloons, Revenue (2004-2018) 20011.1.4 Arteriotomy Closure Devices, Revenue (2004-2018) 20411.1.5 Intravascular Ultrasound Systems (IVUS), Revenue (2004-2018) 20811.2 Interventional Cardiology Overall Volume (2004-2018) 21211.2.1 Cardiac Catheters, Volume (2004-2018) 21611.2.2 Coronary Stents, Volume (2004-2018) 21911.2.3 PTCA Balloons, Volume (2004-2018) 22211.2.4 Arteriotomy Closure Devices, Volume (2004-2018) 22611.2.5 Intravascular Ultrasound Systems (IVUS), Volume (2004-2018) 23011.3 Interventional Cardiology Average Price (2004-2018) 23411.4 Interventional Cardiology Distribution Share (2010-2011) 23611.5 Interventional Cardiology, Norway, Company Share (2010-2011) 23712 Peripheral Vascular Devices In Norway 23912.1 Peripheral Vascular Devices Overall Revenue, (2004-2018) 23912.1.1 Stent Grafts, Revenue (2004-2018) 24312.1.2 Inferior Vena Cava Filters (IVCF), Revenue (2004-2018) 24712.1.3 Peripheral Guidewires, Revenue (2004-2018) 25112.1.4 Peripheral Vascular Stents, Revenue (2004-2018) 25512.1.5 Peripheral Embolic Protection Devices, Revenue (2004-2018) 25912.2 Peripheral Vascular Devices Overall Volume (2004-2018) 26312.2.1 Stent Grafts, Volume (2004-2018) 26712.2.2 Inferior Vena Cava Filters (IVCF), Volume (2004-2018) 27012.2.3 Peripheral Guidewires, Volume (2004-2018) 27412.2.4 Peripheral Vascular Stents, Volume (2004-2018) 27812.2.5 Peripheral Embolic Protection Devices, Volume (2004-2018) 28212.3 Peripheral Vascular Devices Average Price (2004-2018) 28612.4 Peripheral Vascular Devices Distribution Share (2010-2011) 28812.5 Peripheral Vascular Devices, Norway, Company Share (2010-2011) 28913 Prosthetic Heart Valves In Norway 29113.1 Prosthetic Heart Valves Overall Revenue, (2004-2018) 291
  5. 5. 13.1.1 Mechanical Heart Valves, Revenue (2004-2018) 29513.1.2 Tissue Heart Valves, Revenue (2004-2018) 29913.2 Prosthetic Heart Valves Overall Volume (2004-2018) 30313.2.1 Mechanical Heart Valves, Volume (2004-2018) 30513.2.2 Tissue Heart Valves, Volume (2004-2018) 30913.3 Prosthetic Heart Valves Average Price (2004-2018) 31313.4 Prosthetic Heart Valves Distribution Share (2010-2011) 31413.5 Prosthetic Heart Valves, Norway, Company Share (2010-2011) 31514 Overview of Key Companies in Norway Cardiovascular Devices Market 31714.1 Medtronic, Inc. 31714.1.1 Company Overview 31714.2 Boston Scientific Corporation 31714.2.1 Company Overview 31714.3 St. Jude Medical, Inc. 31814.3.1 Company Overview 31814.4 Cordis Corporation 31814.4.1 Company Overview 31814.5 Abbott Laboratories 31914.5.1 Company Overview 31914.6 Edwards Lifesciences Corporation 31914.6.1 Company Overview 31914.7 Sorin S.p.A. 32014.7.1 Company Overview 32014.8 Biotronik SE & Co. KG 32014.8.1 Company Overview 32014.9 C. R. Bard, Inc. 32114.9.1 Company Overview 32114.10 Terumo Corporation 32114.10.1 Company Overview 32114.11 Biosense Webster, Inc. 32214.11.1 Company Overview 32214.12 Philips Healthcare 32214.12.1 Company Overview 32214.13 MAQUET GmbH & Co. KG 32214.13.1 Company Overview 32214.14 AGA Medical Holdings, Inc. 32314.14.1 Company Overview 32314.15 Zoll Medical Corporation 32314.15.1 Company Overview 32314.16 Biosensors International Group, Ltd. 32414.16.1 Company Overview 32414.17 Thoratec Corporation 324
  6. 6. 14.17.1 Company Overview 32414.18 GE Healthcare 32514.18.1 Company Overview 32514.19 ev3 Inc. 32514.19.1 Company Overview 32514.20 Volcano Corporation 32614.20.1 Company Overview 32614.21 Berlin Heart GmbH 32614.21.1 Company Overview 32614.22 HeartWare International, Inc. 32614.22.1 Company Overview 32614.23 Cardiac Science Corporation 32714.23.1 Company Overview 32714.24 Teleflex Incorporated 32714.24.1 Company Overview 32714.25 Welch Allyn Inc. 32814.25.1 Company Overview 32814.26 Nihon Kohden Corporation 32814.26.1 Company Overview 32814.27 Schiller AG 32914.27.1 Company Overview 32914.28 B. Braun Melsungen AG 32914.28.1 Company Overview 32914.29 W. L. Gore & Associates, Inc. 33014.29.1 Company Overview 33014.30 Fukuda Denshi Co., Ltd. 33014.30.1 Company Overview 33014.31 OSI Systems, Inc. 33014.31.1 Company Overview 33014.32 Opto Circuits India Limited 33114.32.1 Company Overview 33114.33 CareFusion Corporation 33114.33.1 Company Overview 33114.34 Covidien plc 33214.34.1 Company Overview 33215 Appendix 33315.1 Global Markets Direct Research Methodology 33315.2 Definitions of Markets Covered in the Report 33415.2.1 Cardiovascular Devices 33415.3 Secondary Research 34815.4 Primary Research 34815.5 Models 349
  7. 7. 15.6 Forecasts 34915.7 Expert Panel Validation 34915.8 Currency Conversion 35015.9 Contact Us 35015.10 Disclaimer 3501.1 List of TablesTable 1: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 21Table 2: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, Historic, 2004-2011 23Table 3: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 25Table 4: Cardiovascular Devices, Norway, Company Share by Revenue ($m), USD Constant,2010-2011 27Table 5: Cardiac Assist Devices, Norway, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 29Table 6: Cardiac Assist Devices, Norway, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 31Table 7: Intra-Aortic Balloon Pumps, Norway, Revenue ($m*) USD Constant, by Sub-Segment,Historic, 2004-2011 33Table 8: Intra-Aortic Balloon Pumps, Norway, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 35Table 9: Ventricular Assist Devices, Norway, Revenue ($m*) USD Constant, by Sub-Segment,Historic, 2004-2011 37Table 10: Ventricular Assist Devices, Norway, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 39Table 11: Cardiac Assist Devices, Norway, Volume (Units) by Segment, Historic, 2004-2011 40Table 12: Cardiac Assist Devices, Norway, Volume (Units) by Segment, Forecast, 2011-2018 41Table 13: Intra-Aortic Balloon Pumps, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 43Table 14: Intra-Aortic Balloon Pumps, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 45Table 15: Ventricular Assist Devices, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 47Table 16: Ventricular Assist Devices, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 49Table 17: Cardiac Assist Devices, Norway, Average Price ($), Historic, 2004-2011 50Table 18: Cardiac Assist Devices, Norway, Average Price ($), Forecast, 2011-2018 50Table 19: Cardiac Assist Devices, Norway, Distribution Share by Revenue ($m), USD Constant,2010-2011 51Table 20: Cardiac Assist Devices, Norway, Company Share by Revenue ($m), USD Constant,2010-2011 53
  8. 8. Table 21: Cardiac Rhythm Management, Norway, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 55Table 22: Cardiac Rhythm Management, Norway, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 57Table 23: Cardiac Resynchronisation Therapy, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 59Table 24: Cardiac Resynchronisation Therapy, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 61Table 25: Implantable Cardioverter Defibrillators, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 63Table 26: Implantable Cardioverter Defibrillators, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 65Table 27: Pacemakers, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 67Table 28: Pacemakers, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 69Table 29: Cardiac Rhythm Management, Norway, Volume (Units) by Segment, Historic, 2004-2011 71Table 30: Cardiac Rhythm Management, Norway, Volume (Units) by Segment, Forecast, 2011-2018 73Table 31: Cardiac Resynchronisation Therapy, Norway, Volume (Units) by Sub-Segment, Historic,2004-2011 75Table 32: Cardiac Resynchronisation Therapy, Norway, Volume (Units) by Sub-Segment,Forecast, 2011-2018 77Table 33: Implantable Cardioverter Defibrillators, Norway, Volume (Units) by Sub-Segment,Historic, 2004-2011 79Table 34: Implantable Cardioverter Defibrillators, Norway, Volume (Units) by Sub-Segment,Forecast, 2011-2018 81Table 35: Pacemakers, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 83Table 36: Pacemakers, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 84Table 37: Cardiac Rhythm Management, Norway, Average Price ($), Historic, 2004-2011 85Table 38: Cardiac Rhythm Management, Norway, Average Price ($), Forecast, 2011-2018 86Table 39: Cardiac Rhythm Management, Norway, Distribution Share by Revenue ($m), USDConstant, 2010-2011 87Table 40: Cardiac Rhythm Management, Norway, Company Share by Revenue ($m), USDConstant, 2010-2011 89Table 41: Cardiovascular Monitoring and Diagnostic Devices, Norway, Revenue ($m*) USDConstant, by Segment, Historic, 2004-2011 91Table 42: Cardiovascular Monitoring and Diagnostic Devices, Norway, Revenue ($m*) USDConstant, by Segment, Forecast, 2011-2018 93Table 43: Cardiovascular Monitoring and Diagnostic Devices, Norway, Volume (Units) bySegment, Historic, 2004-2011 95
  9. 9. Table 44: Cardiovascular Monitoring and Diagnostic Devices, Norway, Volume (Units) bySegment, Forecast, 2011-2018 97Table 45: Cardiovascular Monitoring and Diagnostic Devices, Norway, Average Price ($), Historic,2004-2011 98Table 46: Cardiovascular Monitoring and Diagnostic Devices, Norway, Average Price ($),Forecast, 2011-2018 98Table 47: Cardiovascular Monitoring and Diagnostic Devices, Norway, Distribution Share byRevenue ($m), USD Constant, 2010-2011 99Table 48: Cardiovascular Monitoring and Diagnostic Devices, Norway, Company Share byRevenue ($m), USD Constant, 2010-2011 101Table 49: Cardiovascular Prosthetic Devices, Norway, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 103Table 50: Cardiovascular Prosthetic Devices, Norway, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 105Table 51: Septal Occluders, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 107Table 52: Septal Occluders, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 109Table 53: Cardiovascular Prosthetic Devices, Norway, Volume (Units) by Segment, Historic, 2004-2011 111Table 54: Cardiovascular Prosthetic Devices, Norway, Volume (Units) by Segment, Forecast,2011-2018 113Table 55: Septal Occluders, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 115Table 56: Septal Occluders, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 117Table 57: Cardiovascular Prosthetic Devices, Norway, Average Price ($), Historic, 2004-2011 118Table 58: Cardiovascular Prosthetic Devices, Norway, Average Price ($), Forecast, 2011-2018118Table 59: Cardiovascular Prosthetic Devices, Norway, Distribution Share by Revenue ($m), USDConstant, 2010-2011 119Table 60: Cardiovascular Prosthetic Devices, Norway, Company Share by Revenue ($m), USDConstant, 2010-2011 121Table 61: Cardiovascular Surgery, Norway, Revenue ($m*) USD Constant, by Segment, Historic,2004-2011 123Table 62: Cardiovascular Surgery, Norway, Revenue ($m*) USD Constant, by Segment, Forecast,2011-2018 125Table 63: Beating Heart Surgery Systems, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 127Table 64: Beating Heart Surgery Systems, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 129Table 65: Perfusion Disposables, Norway, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 131Table 66: Perfusion Disposables, Norway, Revenue ($m) USD Constant, by Sub-Segment,
  10. 10. Forecast, 2011-2018 133Table 67: Cardiovascular Surgery, Norway, Volume (Units) by Segment, Historic, 2004-2011 135Table 68: Cardiovascular Surgery, Norway, Volume (Units) by Segment, Forecast, 2011-2018 137Table 69: Beating Heart Surgery Systems, Norway, Volume (Units) by Sub-Segment, Historic,2004-2011 139Table 70: Beating Heart Surgery Systems, Norway, Volume (Units) by Sub-Segment, Forecast,2011-2018 141Table 71: Perfusion Disposables, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011143Table 72: Perfusion Disposables, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018144Table 73: Cardiovascular Surgery, Norway, Average Price ($), Historic, 2004-2011 145Table 74: Cardiovascular Surgery, Norway, Average Price ($), Forecast, 2011-2018 145Table 75: Cardiovascular Surgery, Norway, Distribution Share by Revenue ($m), USD Constant,2010-2011 146Table 76: Cardiovascular Surgery, Norway, Company Share by Revenue ($m), USD Constant,2010-2011 148Table 77: Electrophysiology, Norway, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 150Table 78: Electrophysiology, Norway, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 152Table 79: Electrophysiology Diagnostic Catheters, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 154Table 80: Electrophysiology Diagnostic Catheters, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 156Table 81: Electrophysiology Ablation Catheters, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 158Table 82: Electrophysiology Ablation Catheters, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 160Table 83: Electrophysiology, Norway, Volume (Units) by Segment, Historic, 2004-2011 162Table 84: Electrophysiology, Norway, Volume (Units) by Segment, Forecast, 2011-2018 163Table 85: Electrophysiology Diagnostic Catheters, Norway, Volume (Units) by Sub-Segment,Historic, 2004-2011 165Table 86: Electrophysiology Diagnostic Catheters, Norway, Volume (Units) by Sub-Segment,Forecast, 2011-2018 167Table 87: Electrophysiology Ablation Catheters, Norway, Volume (Units) by Sub-Segment,Historic, 2004-2011 169Table 88: Electrophysiology Ablation Catheters, Norway, Volume (Units) by Sub-Segment,Forecast, 2011-2018 171Table 89: Electrophysiology, Norway, Average Price ($), Historic, 2004-2011 172Table 90: Electrophysiology, Norway, Average Price ($), Forecast, 2011-2018 172Table 91: Electrophysiology, Norway, Distribution Share by Revenue ($m), USD Constant, 2010-
  11. 11. 2011 173Table 92: Electrophysiology, Norway, Company Share by Revenue ($m), USD Constant, 2010-2011 175Table 93: External Defibrillators, Norway, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 177Table 94: External Defibrillators, Norway, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 179Table 95: External Defibrillators, Norway, Volume (Units) by Segment, Historic, 2004-2011 181Table 96: External Defibrillators, Norway, Volume (Units) by Segment, Forecast, 2011-2018 183Table 97: External Defibrillators, Norway, Average Price ($), Historic, 2004-2011 184Table 98: External Defibrillators, Norway, Average Price ($), Forecast, 2011-2018 184Table 99: External Defibrillators, Norway, Distribution Share by Revenue ($m), USD Constant,2010-2011 185Table 100: External Defibrillators, Norway, Company Share by Revenue ($m), USD Constant,2010-2011 187Table 101: Interventional Cardiology, Norway, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 189Table 102: Interventional Cardiology, Norway, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 191Table 103: Cardiac Catheters, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 193Table 104: Cardiac Catheters, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 195Table 105: Coronary Stents, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 197Table 106: Coronary Stents, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 199Table 107: PTCA Balloons, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 201Table 108: PTCA Balloons, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 203Table 109: Arteriotomy Closure Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 205Table 110: Arteriotomy Closure Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 207Table 111: Intravascular Ultrasound Systems (IVUS), Norway, Revenue ($m) USD Constant, bySub-Segment, Historic, 2004-2011 209Table 112: Intravascular Ultrasound Systems (IVUS), Norway, Revenue ($m) USD Constant, bySub-Segment, Forecast, 2011-2018 211Table 113: Interventional Cardiology, Norway, Volume (Units) by Segment, Historic, 2004-2011213Table 114: Interventional Cardiology, Norway, Volume (Units) by Segment, Forecast, 2011-2018
  12. 12. 215Table 115: Cardiac Catheters, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 217Table 116: Cardiac Catheters, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018218Table 117: Coronary Stents, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 220Table 118: Coronary Stents, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 221Table 119: PTCA Balloons, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 223Table 120: PTCA Balloons, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 225Table 121: Arteriotomy Closure Devices, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 227Table 122: Arteriotomy Closure Devices, Norway, Volume (Units) by Sub-Segment, Forecast,2011-2018 229Table 123: Intravascular Ultrasound Systems (IVUS), Norway, Volume (Units) by Sub-Segment,Historic, 2004-2011 231Table 124: Intravascular Ultrasound Systems (IVUS), Norway, Volume (Units) by Sub-Segment,Forecast, 2011-2018 233Table 125: Interventional Cardiology, Norway, Average Price ($), Historic, 2004-2011 234Table 126: Interventional Cardiology, Norway, Average Price ($), Forecast, 2011-2018 235Table 127: Interventional Cardiology, Norway, Distribution Share by Revenue ($m), USDConstant, 2010-2011 236Table 128: Interventional Cardiology, Norway, Company Share by Revenue ($m), USD Constant,2010-2011 238Table 129: Peripheral Vascular Devices, Norway, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 240Table 130: Peripheral Vascular Devices, Norway, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 242Table 131: Stent Grafts, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 244Table 132: Stent Grafts, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 246Table 133: Inferior Vena Cava Filters (IVCF), Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 248Table 134: Inferior Vena Cava Filters (IVCF), Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 250Table 135: Peripheral Guidewires, Norway, Revenue ($m*) USD Constant, by Sub-Segment,Historic, 2004-2011 252Table 136: Peripheral Guidewires, Norway, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 254Table 137: Peripheral Vascular Stents, Norway, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 256Table 138: Peripheral Vascular Stents, Norway, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 258
  13. 13. Table 139: Peripheral Embolic Protection Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 260Table 140: Peripheral Embolic Protection Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 262Table 141: Peripheral Vascular Devices, Norway, Volume (Units) by Segment, Historic, 2004-2011264Table 142: Peripheral Vascular Devices, Norway, Volume (Units) by Segment, Forecast, 2011-2018 266Table 143: Stent Grafts, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 268Table 144: Stent Grafts, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 269Table 145: Inferior Vena Cava Filters (IVCF), Norway, Volume (Units) by Sub-Segment, Historic,2004-2011 271Table 146: Inferior Vena Cava Filters (IVCF), Norway, Volume (Units) by Sub-Segment, Forecast,2011-2018 273Table 147: Peripheral Guidewires, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011275Table 148: Peripheral Guidewires, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018277Table 149: Peripheral Vascular Stents, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 279Table 150: Peripheral Vascular Stents, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 281Table 151: Peripheral Embolic Protection Devices, Norway, Volume (Units) by Sub-Segment,Historic, 2004-2011 283Table 152: Peripheral Embolic Protection Devices, Norway, Volume (Units) by Sub-Segment,Forecast, 2011-2018 285Table 153: Peripheral Vascular Devices, Norway, Average Price ($), Historic, 2004-2011 286Table 154: Peripheral Vascular Devices, Norway, Average Price ($), Forecast, 2011-2018 287Table 155: Peripheral Vascular Devices, Norway, Distribution Share by Revenue ($m), USDConstant, 2010-2011 288Table 156: Peripheral Vascular Devices, Norway, Company Share by Revenue ($m), USDConstant, 2010-2011 290Table 157: Prosthetic Heart Valves, Norway, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 292Table 158: Prosthetic Heart Valves, Norway, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 294Table 159: Mechanical Heart Valves, Norway, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 296Table 160: Mechanical Heart Valves, Norway, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 298Table 161: Tissue Heart Valves, Norway, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 300
  14. 14. Table 162: Tissue Heart Valves, Norway, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 302Table 163: Prosthetic Heart Valves, Norway, Volume (Units) by Segment, Historic, 2004-2011 303Table 164: Prosthetic Heart Valves, Norway, Volume (Units) by Segment, Forecast, 2011-2018304Table 165: Mechanical Heart Valves, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 306Table 166: Mechanical Heart Valves, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 308Table 167: Tissue Heart Valves, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011310Table 168: Tissue Heart Valves, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018312Table 169: Prosthetic Heart Valves, Norway, Average Price ($), Historic, 2004-2011 313Table 170: Prosthetic Heart Valves, Norway, Average Price ($), Forecast, 2011-2018 313Table 171: Prosthetic Heart Valves, Norway, Distribution Share by Revenue ($m), USD Constant,2010-2011 314Table 172: Prosthetic Heart Valves, Norway, Company Share by Revenue ($m), USD Constant,2010-2011 3161.2 List of FiguresFigure 1: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 20Figure 2: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, Historic, 2004-2011 22Figure 3: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 24Figure 4: Cardiovascular Devices, Norway, Company Share (%), 2011 26Figure 5: Cardiac Assist Devices, Norway, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 28Figure 6: Cardiac Assist Devices, Norway, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 30Figure 7: Intra-Aortic Balloon Pumps, Norway, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 32Figure 8: Intra-Aortic Balloon Pumps, Norway, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 34Figure 9: Ventricular Assist Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 36Figure 10: Ventricular Assist Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 38Figure 11: Cardiac Assist Devices, Norway, Volume (Units) by Segment, Historic, 2004-2011 40Figure 12: Cardiac Assist Devices, Norway, Volume (Units) by Segment, Forecast, 2011-2018 41Figure 13: Intra-Aortic Balloon Pumps, Norway, Volume (Units) by Sub-Segment, Historic, 2004-
  15. 15. 2011 42Figure 14: Intra-Aortic Balloon Pumps, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 44Figure 15: Ventricular Assist Devices, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 46Figure 16: Ventricular Assist Devices, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 48Figure 17: Cardiac Assist Devices, Norway, Company Share (%), 2011 52Figure 18: Cardiac Rhythm Management, Norway, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 54Figure 19: Cardiac Rhythm Management, Norway, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 56Figure 20: Cardiac Resynchronisation Therapy, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 58Figure 21: Cardiac Resynchronisation Therapy, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 60Figure 22: Implantable Cardioverter Defibrillators, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 62Figure 23: Implantable Cardioverter Defibrillators, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 64Figure 24: Pacemakers, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 66Figure 25: Pacemakers, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 68Figure 26: Cardiac Rhythm Management, Norway, Volume (Units) by Segment, Historic, 2004-2011 70Figure 27: Cardiac Rhythm Management, Norway, Volume (Units) by Segment, Forecast, 2011-2018 72Figure 28: Cardiac Resynchronisation Therapy, Norway, Volume (Units) by Sub-Segment,Historic, 2004-2011 74Figure 29: Cardiac Resynchronisation Therapy, Norway, Volume (Units) by Sub-Segment,Forecast, 2011-2018 76Figure 30: Implantable Cardioverter Defibrillators, Norway, Volume (Units) by Sub-Segment,Historic, 2004-2011 78Figure 31: Implantable Cardioverter Defibrillators, Norway, Volume (Units) by Sub-Segment,Forecast, 2011-2018 80Figure 32: Pacemakers, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 82Figure 33: Pacemakers, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 84Figure 34: Cardiac Rhythm Management, Norway, Company Share (%), 2011 88Figure 35: Cardiovascular Monitoring and Diagnostic Devices, Norway, Revenue ($m) USDConstant, by Segment, Historic, 2004-2011 90Figure 36: Cardiovascular Monitoring and Diagnostic Devices, Norway, Revenue ($m) USD
  16. 16. Constant, by Segment, Forecast, 2011-2018 92Figure 37: Cardiovascular Monitoring and Diagnostic Devices, Norway, Volume (Units) bySegment, Historic, 2004-2011 94Figure 38: Cardiovascular Monitoring and Diagnostic Devices, Norway, Volume (Units) bySegment, Forecast, 2011-2018 96Figure 39: Cardiovascular Monitoring and Diagnostic Devices, Norway, ComContact: sales@reportsandreports.com for more information.

×